Detection of polymorphisms at cytosine phosphoguanadine dinucleotides and diagnosis of haemophilia B carriers
- PMID: 2564457
- DOI: 10.1016/s0140-6736(89)92141-7
Detection of polymorphisms at cytosine phosphoguanadine dinucleotides and diagnosis of haemophilia B carriers
Abstract
The polymerase chain reaction procedure (PCR) was used to detect a polymorphic Hha I site adjacent to the factor IX locus in a panel of 33 phenotypically normal caucasian individuals. This technique was also applied to a haemophilia B family pedigree. The Hha I polymorphic site was located 8 kb 3' to the factor IX gene, and the proportion of female subjects expected to be heterozygous at this site was 0.48. The Hha I locus was in linkage equilibrium with the other polymorphic loci on the factor IX gene. These findings, besides increasing the proportion of caucasian individuals whose haemophilia B carrier state can be diagnosed from 79% to 89%, demonstrate this widely applicable use of PCR for the detection of DNA polymorphism at cytosine phosphoguanadine dinucleotides irrespective of the methylation status.
Comment in
-
CpG polymorphisms and haemophilia B.Lancet. 1989 Aug 26;2(8661):502-3. doi: 10.1016/s0140-6736(89)92111-9. Lancet. 1989. PMID: 2570208 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
